FATE
Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.95 / 10
Netural
The fund flow profile scores 7.9/10, demonstrating robust fund flow characteristics. Favorable overall, block, Small, and Extra-large movements are tempered by challenging Medium and Large dynamics, supporting positive flow assessment. Analyst perspective reveals predominantly positive analyst sentiment with moderate confidence. Rating breakdown: Strong Buy(33.3%), Buy(33.3%), Neutral(33.3%) from 3 analyst assessments, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-27
InstitutionWedbush
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for FATE?
- FATE holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.95/10 (Netural).
